INTRODUCTION
Platelet transfusions are routinely needed as an essential part of treatment for patients undergoing cancer therapy, as well as for those with bleeding disorders, and for patients undergoing open-heart surgery, or organ transplantation [1] . Platelets can be harvested using plateletpheresis, a process whereby whole blood is removed from a donor, separating the blood into its components, keeping the platelets and returning the remaining blood components to the donor; or by separating platelets from units of whole blood [2, 3] . Platelets must be transfused within five days of collection due to their very short shelf-life [4] . Therfore there is a need for constant replenishment of the hospital supply. It is reported that platelet donations can be made up to 24 times per year [5] .
However, there is relatively little information about the biochemical and physiological changes in response to plateletpheresis in healthy donors, especially because citrate is routinely used for the collection process to inhibit coagulation, and may lead to metabolic alkalosis. Indeed, it was reported that exposure to citrate during the apheresis procedure may acutely affect mineral and bone metabolism, leading to an increase in serum parathyroid hormone, and a fall in serum albumin, calcium and 25 hydroxy vitamin D levels. This has been shown to compromise bone mineral density at the lumbar spine. [2] . Over the years, the thrombopoietic response to plateletpheresis has been investigated [3, 4, 5] . After plateletpheresis, platelet counts were reported to increase by some [3, 4] , and was reported to fall in one study [5] . In addition, serum ferritin levels of the female donors, but not male donors, has been reported to be decreased with increasing frequency of apheresis donation [5] .
A more recent study has investigated the effects of phlebotomy on insulin sensitivity and cardiovascular risk factors in patients with metabolic syndrome, and concluded that consecutive reduction of body iron stores, lowered BP and resulted in improvements in markers of cardiovascular risk including low-density lipoprotein/high-density lipoprotein ratio, and glycemic control. [6] . Whether such an effect is produced after plateletpheresis only is not known. Therefore, we aimed to investigate the effects of plateletpheresis on biochemical tests of glycemic status, insulin resistance, lipid profile, inflammatory markers and iron stores in plateletpheresis donors,
MATERIALS AND METHODS
Thirteen male first time donors were recruited from donation area at the apheresis facility. Exclusion criteria included: diagnosed hypertension, treatment with oral hypoglycaemic drugs, insulin, or other drugs likely to modify insulin resistance and coagulation [7] . Subjects were also excluded if test results suggested abnormalities in glucose tolerance, or iron stores, or if they had a current acute symptoms, or if there were other contraindications to apheresis. After applying exclusion criteria three donors were rejected after the first visit due to impaired glucose tolerance. A standard donor questionnaire was used to verify eligibility for platelet donation, and a pre-procedure CBC is done to ensure that the donor platelet count is >150,000 per mm³, with donor consent being obtained before donation as usual. available the glycaemic status of each participant was categorized according to WHO criteria [8] . All ten subjects were classified as having normal glucose tolerance following the first OGTT. Each subject also had their blood pressure measured using an automated equipment (V100 DINAMAP, General Electric) before blood collection.Plateletpheresis was undertaken later the same day using a standard protocol at the apheresis facility.
To monitor the effects of plateletpheresis on biochemical parameters, subjects returned for a second visit (visit B) 24 hours after plateletpheresis. A second OGTT was carried out as described at the first visit. Eight days later a third OGTT was performed (visit C), Architect c8000. LDL-cholesterol was calculated using the Friedewald formula [9] .
Glycated hemoglobin (HbA1c) test was performed using a high-pressure liquid chromatography (HPLC) method on a G8-TOSOH Bioscience, Inc instrument. The principle of chemiluminescent immunoassay on Architect i1000 was utilized to measure insulin and ferritin levels in serum.
Indices of insulin resistance
The index ISI-gly (insulin sensitivity index-glycaemia) was calculated based on the fasting and two hour glucose and insulin values using the following formula [10] :
Where insulin and glucoserepresent the sum of measurements of insulin (mU/L) and glucose mg/dL) taken at baseline and 2 hours during OGTT.
Homeostasis model assessment-insulin resistance (HOMA-IR) and β-cell activity (HOMA-β) were calculated based on fasting levels only using the following two formula [11] :
Statistics
The study was designed to detect mainly the difference between the baseline visit and other visits. Results are expressed as mean± SD or otherwise indicated. Data were transformed using natural logarithm (Ln) to approximate a normal distribution if necessary. Comparisons between means were performed using Paired Student's t-test at 95% confidence interval. Repeated measures one way ANOVA was used to compare means between different visits for the same individuals. Mauchly's test statistic was evaluated for sphericity violation before concluding if there are significant differences between the variance of differences. P values <0.05 were considered significant. SPSS software (version 24) was used for statistical analysis.
RESULTS
All 10 male subjects were from a Saudi population and had a normal glucose tolerance (NGT). The age and body mass index (BMI) and other anthropometric measurements are shown in Table 1 . Subjects were all under 50 years of age, and either of normal BMI, or overweight.
Changes in different biochemical parameters before and after blood donation are shown in Table 2 .
Glucose and insulin resistance
Compared to the baseline levels, fasting plasma glucose (5.1 ± 0.6 mmol/L) was significantly lower (4.9 ± 0.5 mmol/L; p< 0.05) at visit B (Table 2) 
Glycated haemoglobin (HbA1c)
HbA1c fell in almost all subjects at visit D with a maximum reduction of -5.8%, increasing by +1.7 % in one subject only (Figure 1) , and the mean level was significantly lower (5.37% ± 0.38, p<0.01) when compared to the baseline level (5.48% ± 0.32) (Figure 2, A) . Moreover, the difference across the study period was highly significant; using repeated ANOVA; p= 0.008, F = 4.99 (Table 2) . 
Lipid profile

Iron profile
Iron levels fluctuated throughout the study, showing an increase at visits B (19.5%), and D (12.1%), but not C (-7.5%) when compared to the baseline level (visit A). Differences throughout different visits were not significant using repeated ANOVA (F = 2.11, p = 0.12).
Serum transferrin was significantly lower at visit B (-2.7%, p<0.05) but not C (-4.6%, p= 0.12) or D (2.3%, p=0.32).
Following plateletpheresis iron stores which were assessed using serum ferritin, gradually decreased throughout different visits (B, -3.2%, p = 0.65; C, -9.6%, p = 0.44; D, -18.1%, p <0.05) (Figure 2, B) . However, there were no significant changes using repeated ANOVA (F = 2.16, p = 0.12).
Other indices
After plateletpheresis, there was no change in levels of serum uric acid at any of the visits (Table 2) . The inflammatory marker, CRP, increased at visit B (27.1%) and C (40.9%).
At visit D the level became fell to near the baseline level (-9.1%). CRP was not significantly different using repeated ANOVA (F = 0.67, p = 0.44).
DISCUSSION
Previous studies on the changes in biochemical parameters after plateletpheresis in healthy individuals are limited; our findings show some potentially important effects. A reduction in iron stores after repeated plateletpheresis in males and females, and a correlation between iron depletion and frequency of pheresis donation in male donors has been noted previously [12] . However, this was done by comparing stores in donors and non-donors, not by investigating the effect on the individual donors. In another study carried out on Japanese donors, serum ferritin levels were found to fall with donationfrequency in female donors, [13] . In our study on first time male donors there was a gradual decrease in iron stores, measured by ferritin level, following plateletpheresis over the study period, with statistical significance being noted at visit D. However, no values were found outside the reference range. This is the first report in literature of decreased iron stores following one single donation. Difference between our results and that of other studies could be due to difference in research design, as well as differences in studied population.
The effect of plateletpheresis on glucose homeostasis and glycemic control is difficult to The overall decrease in the mean of HbA1c percentage over the study period suggests an improvement in one of the main diagnostic test of diabetes. A decrease in HbA1c with a maximal reduction at the fourth week following whole blood donation was obtained by
Starkman et al., [14] . However, this is the first time to show that, not only whole blood donation but even plateletpheresis can reduce HbA1c towards a lower level. Such an effect was expected after whole blood donation but not after plateletpheresis because the amount of whole blood lost in this process is limited (80 to 100 mL) compared to whole blood donation (450 mL). The possible reason behind this decrease is unclear but it could be due to other artefactual effects. To interpret the value of the change in A1c, the effect of reference change values (RCV) must be discussed. RCV is defined as the critically significant changes between two results. It is important for determining whether apparent changes in serial results reflect real changes or can be accounted for by biological variation alone [17] . RCV of ±5.4%
was previously reported for HbA1c in healthy individuals using the same HPLC method but without any intervention [18] . However, the RCV in our population was not determined, and despite the statistically significant decrease in HbA1c at visit D in our participants, the total change in percentage compared to baseline was only approximately -2.0%, hence does not exceed the previously reported RCV of ±5.4%.
Changes in HbA1c in each involved participant did not exceed the limit of RCV of ±5.4% except in one subject where the change was -5.8%. Variations in HbA1c between different individuals after whole blood donation was investigated before and it was concluded that it may depend on the effectiveness of erythropoiesis which subsequently depends on sufficient iron stores [19] . Therefore, the same conclusion may be applied on HbA1c variability between different subjects after plateletpheresis. Whether our findings of a decrease in HbA1c reflects a real effect of plateletpheresis in reducing
HbA1c levels in non-diabetic individuals is worthy of further investigation, especially in type 2 diabetic donors. Our findings may also suggest that lower ferritin levels at visit D compared to baseline could contribute to enhanced insulin sensitivity for HOMA-IR. This observation is in line with the previously published results about whole blood donation [20] . Hence, it could be suggested that platletpheresis may increase the removal of free transition metals, including iron from the body. This may lead to a reduction in the oxidation susceptibility of end products of serum glycated proteins, which are thought to have potential toxic effects resulting in increased insulin resistance [21, 22] . However, if plateletpheresis is associated with the selective removal of old RBCs, due to the reasons suggested above, then this may lead to the mobilization of iron stores to make new RBCs.
At the first visit 24 hours after plateletpheresis (visit B), total cholesterol, and its estimated fractions were significantly decreased, in contrast to triglycerides which was significantly increased. Such changes may be important to consider if the patient is being treated with lipid lowering agents. In addition, the medical assessment of new donors recruited to platletpheresis program should include a venous blood sample taken prior to initial donation. This trend of decrease in blood cholesterol and LDL-C after plateletpheresis is consistent with the control subjects involved in Houschyar et.al, study [6] . As triglycerides level is diet dependent then the increased level can be related to the timing of the last meal of each individual subject.
When the RCV principle is applied to lipid parameters using the same methods and autoanalyser (Architect c8000), the RCVs for glucose, total cholesterol, triglyceride and HDL-C and were reported as ±14.63%, ±14.19%, ±46.62% and ±20.51% respectively [23] . Based on these values, changes in the analytes were not considered clinically significant.
After plateletpheresis, no significant changes were observed for serum urate.
Furthermore, although a progressive increase in serum CRP was noticed after plateletpheresis for up to 8 days, the difference was not significant from the baseline level. This increased level of CRP could be due to the induced citrate solution during the process of platletpheresis, but this point may need further investigation.
One of the main limitations of the present study is the relatively small number of involved subjects. However, the numbers were sufficient to detect changes in this pilot study, and to stimulate further studies. The second limitation was the use of simple surrogate indices of insulin resistance only, which are appropriate for preliminary investigations but they do suffer from some important limitations that have been discussed previously [24, 25] .
In summary, although changes in glycaemic control, serum lipids and iron stores are not likely to be clinically significant, they do suggest that there needs to be a careful interpretation of the blood test results of individuals after plateletpheresis. Such potential changes can be detected at 1 and 22 days after donation. Future larger studies with more 
